# Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

> **NCT04020510** · PHASE4 · RECRUITING · sponsor: **Walter Reed National Military Medical Center** · enrollment: 184 (estimated)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** onaBoNT-A

## Key facts

- **NCT ID:** NCT04020510
- **Lead sponsor:** Walter Reed National Military Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-07-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04020510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04020510, "Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04020510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*